Pharmacokinetics of Lumiracoxib in Plasma and Synovial Fluid

Authors:
  • DRDennis A Ruff
    Dennis A Ruff

Abstract
Background umiracoxib is a new cyclo-oxygenase-2 (COX-2) selective inhibitor in development for the treatment of rheumatoid arthritis, osteoarthritis and acute pain.

This publication has 28 references indexed in Scilit: